Gregory J. Tibbitts - 01 Jan 2026 Form 3 Insider Report for MAINZ BIOMED N.V. (MYNZ)

Role
Director
Signature
/s/ Gregory Tibbits
Issuer symbol
MYNZ
Transactions as of
01 Jan 2026
Net transactions value
$0
Form type
3
Filing time
26 Jan 2026, 16:04:22 UTC
Next filing
19 Feb 2026
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Tibbitts Gregory J Director MAINZ BIOMED N.V., ROBERT KOCH STRASSE 50, MAINZ, GERMANY /s/ Gregory Tibbits 26 Jan 2026 0001326220

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding MYNZ Ordinary Shares 0 01 Jan 2026 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding MYNZ Employee Stock Option (Right to Buy) 01 Jan 2026 Ordinary Shares 10,000 $4.95 Direct F1
holding MYNZ Employee Stock Option (Right to Buy) 01 Jan 2026 Ordinary Shares 625 $356.40 Direct F2
holding MYNZ Employee Stock Option (Right to Buy) 01 Jan 2026 Ordinary Shares 250 $302.80 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 50% of the option vested upon grant on 03/04/2025; the remaining balance vests 25% on 03/24/26 and 25% on 03/04/2027.
F2 Fully vested.